Nimodipina Labesfal 30 mg Comprimido revestido
Country: Portugal
Language: Portuguese
Source: INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Nimodipina
Available from:
Labesfal - Laboratórios Almiro, S.A.
ATC code:
C08CA06
INN (International Name):
Nimodipine
Dosage:
30 mg
Pharmaceutical form:
Comprimido revestido
Composition:
Nimodipina 30 mg
Administration route:
Via oral
Units in package:
Blister 60 unidade(s)
Class:
3.4.3 - Bloqueadores da entrada do cálcio
Prescription type:
MSRM
Therapeutic group:
N/A
Therapeutic area:
nimodipine
Therapeutic indications:
Duração do Tratamento: Longa Duração
Product summary:
Número de Registo: 3111994 CNPEM: 50066781 CHNM: 10007662 Não Comercializado
Authorization status:
Autorizado
Authorization date:
1999-12-22
